Find clinical trials for COVID-19 in Chicago, IL
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
COVID-19 trials near Chicago, IL, USA:
Double-Blind, Randomized, Placebo-Controlled Study to Investigate the Safety and Efficacy of STRI Formula in Non-Hospitalized Participants with COVID...
Phase 2
Oak Forest, Illinois, United States and 12 other locations
The purpose of this study (Part 1 and Part 2) is to evaluate the relative vaccine efficacy (rVE), safety, reactogenicity, and immunogenicity of mRNA-...
Phase 3
Chicago, Illinois, United States of America and 217 other locations
a completed primary series and bivalent booster of mRNA based COVID-19 vaccine and have =\<2500 U/mL SARS-CoV-2 S antibody concentr...
Phase 2
Chicago, Illinois, United States and 5 other locations
in treating high-risk participants who have tested positive for Covid-19. The main question\[s\] it aims to answer are:* To evaluat-...
Phase 2
Berwyn, Illinois, United States and 3 other locations
of the study is to assess the safety and immunogenicity of IIV-HD (high-dose inactivated influenza vaccine) + rC19 (adjuvanted recombinant COVID...
Phase 1, Phase 2
Chicago, Illinois, United States and 11 other locations
(SARS-CoV2) vaccine tablet VXA-CoV2-3.1 compared to a currently recommended vaccine for the prevention of symptomatic Coronavirus Disease 2019 (COVID...
Phase 2
Chicago, Illinois, United States and 144 other locations
seek to enroll immunocompromised patients with Lower Tract parainfluenza infection.It also contains a sub-study to enroll patients with severe COVID...
Phase 3
Chicago, Illinois, United States and 66 other locations
The purpose of the study is to evaluate whether ibuzatrelvir is effective and safe in adults and adolescents with COVID-19 who do n...
Phase 3
Oak Brook, Illinois, United States and 51 other locations
The purpose of this study is to characterize the safety and immunogenicity of AZD9838 and AZD6563 when administered as a single dose vaccination agai...
Phase 1
Chicago, Illinois, United States and 4 other locations
The purpose of this study is to evaluate the immunogenicity, reactogenicity, and safety, of mRNA-1083 multicomponent influenza and COVID-19...
Phase 2
Melrose Park, Illinois, United States and 16 other locations
Clinical trials
Research sites
Resources
Legal